Invited commentary on GETUG-AFU 16

被引:2
|
作者
Lee, W. Robert [1 ]
机构
[1] Duke Univ, Sch Med, Durham, NC 27710 USA
关键词
PROSTATE-CANCER; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; SALVAGE RADIOTHERAPY; ADJUVANT RADIATION; RISK;
D O I
10.21037/tau.2016.11.10
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:958 / 960
页数:3
相关论文
共 50 条
  • [1] Individual patient data analysis of salvage radiotherapy trials: RTOG 0534 and GETUG-AFU 16
    Mohamad, Osama
    Pugh, Stephanie
    Pommier, Pascal
    Pollack, Alan
    Lukka, Himanshu R.
    Rutledge, Robert
    Martin, Andre-Guy
    Patel, Shyamal
    Sarin, David
    Balogh, Alexander G.
    Michalski, Jeff M.
    Vavassis, Peter
    Guerif, Stephane
    Supiot, Stephane
    Latorzeff, Igor
    Chabaud, Sylvie
    Brihoum, Meryem
    Lyness, Jessica
    Sandler, Howard
    Sargos, Paul
    Feng, Felix Y.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2426 - S2427
  • [2] Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)
    Sargos, Paul
    Guerif, Stephane
    Latorzeff, Igor
    Hennequin, Christophe
    Pommier, Pascal
    Lagrange, Jean-Leon
    Crehange, Gilles
    Chapeth, Olivier
    de Crevoisier, Renaud
    Azria, David
    Supiot, Stephane
    Habibian, Muriel
    Soulie, Michel
    Richaud, Pierre
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 814 - 820
  • [3] Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
    Carrie, Christian
    Magne, Nicolas
    Burban-Provost, Patricia
    Sargos, Paul
    Latorzeff, Igor
    Lagrange, Jean-Leon
    Supiot, Stephane
    Belkacemi, Yazid
    Peiffert, Didier
    Allouache, Nedla
    Dubray, Bernard M.
    Servagi-Vernat, Stephanie
    Suchaud, Jean-Philippe
    Crehange, Gilles
    Guerif, Stephane
    Brihoum, Meryem
    Barbier, Nicolas
    Graff-Cailleaud, Pierre
    Ruffion, Alain
    Dussart, Sophie
    Ferlay, Celine
    Chabaud, Sylvie
    LANCET ONCOLOGY, 2019, 20 (12) : 1740 - 1749
  • [4] Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
    Carrie, Christian
    Hasbini, Ali
    de Laroche, Guy
    Richaud, Pierre
    Guerif, Stephane
    Latorzeff, Igor
    Supiot, Stephane
    Bosset, Mathieu
    Lagrange, Jean-Leon
    Beckendorf, Veronique
    Lesaunier, Francois
    Dubray, Bernard
    Wagner, Jean-Philippe
    Tan Dat N'Guyen
    Suchaud, Jean-Philippe
    Crehange, Gilles
    Barbier, Nicolas
    Habibian, Muriel
    Ferlay, Celine
    Fourneret, Philippe
    Ruffion, Alain
    Dussart, Sophie
    LANCET ONCOLOGY, 2016, 17 (06) : 747 - 756
  • [5] GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol
    Pasquier, David
    Le Deley, Marie-Cecile
    Tresch, Emmanuelle
    Cormier, Luc
    Duterque, Martine
    Nenan, Soazig
    Lartigau, Eric
    BMJ OPEN, 2019, 9 (08):
  • [6] The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
    Pasquier, David
    Lacornerie, Thomas
    Supiot, Stephane
    Pommier, Pascal
    Quivrin, Magali
    Simon, Jean-Marc
    Loos, Genevieve
    Meyer, Emmanuel
    Calais, Gilles
    Peiffert, Didier
    Vandendorpe, Benjamin
    Aymes, Estelle
    Leguillette, Clemence
    Brihoum, Meryem
    Nenan, Soazig
    Cormier, Luc
    Le Deley, Marie-Cecile
    Lartigau, Eric F.
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (04): : 399 - 405
  • [7] The French clinical trials ongoing (GETUG and AFU) on urothelial carcinomas, kidney and prostate cancers
    Neuzillet, Y.
    Negrier, S.
    Fizazi, K.
    Pignot, G.
    El Fegoun, A. Benchikh
    Guillotreau, J.
    Culine, S.
    PROGRES EN UROLOGIE, 2010, 20 : S84 - S89
  • [8] Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
    Sargos, Paul
    Chabaud, Sylvie
    Latorzeff, Igor
    Magne, Nicolas
    Benyoucef, Ahmed
    Supiot, Stephane
    Pasquier, David
    Abdiche, Menouar Samar
    Gilliot, Olivier
    Graff-Cailleaud, Pierre
    Silva, Marlon
    Bergerot, Philippe
    Baumann, Pierre
    Belkacemi, Yazid
    Azria, David
    Brihoum, Meryein
    Soulie, Michel
    Richaud, Pierre
    LANCET ONCOLOGY, 2020, 21 (10) : 1341 - 1352
  • [9] Re: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy plus Short-term Androgen Deprivation Therapy in Men with Localised Prostate Cancer After Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 Trial
    Rodriguez-Sanchez, Lara
    Crehangec, Gilles
    Bennamoun, Mostefa
    Macek, Petr
    Cathelineau, Xavier
    Sanchez-Salas, Rafael
    EUROPEAN UROLOGY, 2021, 79 (04) : 555 - 556
  • [10] Invited Commentary: More Surprises From a Gene Desert
    Wacholder, Sholom
    Yeager, Meredith
    Liao, Linda M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 (06) : 488 - 491